scholarly journals Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention

EP Europace ◽  
2013 ◽  
Vol 15 (10) ◽  
pp. 1507-1515 ◽  
Author(s):  
Takekuni Hayashi ◽  
Seiji Fukamizu ◽  
Rintaro Hojo ◽  
Kota Komiyama ◽  
Yasuhiro Tanabe ◽  
...  
Keyword(s):  
Ventricular Tachycardia ◽  
Primary Prevention ◽  
Catheter Ablation ◽  
Implantable Cardioverter Defibrillators ◽  
Monomorphic Ventricular Tachycardia ◽  
Cardioverter Defibrillators

Sustained monomorphic ventricular tachycardia associated with structural heart disease: classification, assessment, and initial treatment

ESC CardioMed ◽  
2018 ◽  
pp. 2265-2270
Author(s):  
Fernando M. Contreras-Valdes ◽  
Peter J. Zimetbaum
Keyword(s):  
Heart Disease ◽  
Ventricular Tachycardia ◽  
Sudden Death ◽  
Beta Blockers ◽  
Substantial Reduction ◽  
Structural Heart Disease ◽  
Disease Classification ◽  
Implantable Cardioverter Defibrillators ◽  
Monomorphic Ventricular Tachycardia ◽  
Cardioverter Defibrillators

Sustained monomorphic ventricular tachycardia occurs in patients with structural heart disease and may lead to syncope, haemodynamic collapse, or sudden death. The diagnosis is established by the electrocardiogram, with cardiac imaging used to determine the underlying substrate. Initial management requires a combination of electrical cardioversion and antiarrhythmic drugs, mainly amiodarone and beta blockers. Nonetheless, implantable cardioverter defibrillators provide the most substantial reduction in sudden death, with catheter ablation becoming an increasingly favoured strategy to minimize shocks and possibly lower mortality from ventricular arrhythmias in this population.

Sign in / Sign up

Export Citation Format

Share Document